Results 91 to 100 of about 282,372 (346)

Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya [PDF]

, 2016
Background: HPV is the major etiological factor in the causal pathway for cervical cancer, which is the leading cancer among women in sub-Saharan Africa. HIV is associated with a higher prevalence and a broader range of high-risk HPV genotypes.
Harebottle, Ronald, Mabeya, Hillary, Menon, Sonia, Rossi, Rodolfo, Vanden Broeck, Davy   +4 more
core   +2 more sources

Challenges in the future of cancer screening

International Journal of Cancer, EarlyView.
Abstract The purpose of cancer screening is to reduce mortality, and ideally incidence, from the cancer screened for. Until recently, cancer screening has been offered to all persons in pre‐defined sex‐ and age‐groups. The exception is lung screening which is targeted to high‐risk individuals.
Elsebeth Lynge, Berit Andersen, Stig E. Bojesen, Lone Kjeld Petersen, Mickael Bech, Martin Bøgsted, Mie Seest Dam, Søren Egstrand, Anne Mette Fløe Hvass, Camilla J. Kobylecki, Kristina Lång, Mads Nielsen, Giorgi Paolo Rossi, Michael Stenger, Ilse Vejborg, Future of Cancer Screening Working Group, Vibe Munk Bertelsen, Janne Bigaard, Karen Omann Binderup, Lennart Friis‐Hansen, Stine Bisgaard Greve, Jessica Xin Hjaltelin, Rikke Hedegaard Jensen, Gitte Jessing, Pia Kirkegaard, Mette Hartmann Nonboe, Tina Bech Olesen, Katrine Stolberg, Signe Bülow Therkildsen, Mette Kielsholm Thomsen   +29 more
wiley   +1 more source

Cervical Cancer-Associated Human Papillomavirus 16 E7 Oncoprotein Inhibits Induction of Anti-Cancer Immunity by a CD4+ T Cell Dependent Mechanism [PDF]

, 2009
Attempts to develop therapeutic vaccines against cervical cancer have been proven difficult. One of the major causes of the failure is due to the use of the wrong mouse models based on transplantable tumours in testing the efficacy of vaccines.
Germain J. Fernando, Jie Zhong, Marion E. G. Brunck, Xiao Song Liu   +3 more
core   +2 more sources

Predicting optimal impact interventions in the post‐HPV vaccination world

International Journal of Cancer, EarlyView.
Abstract Prophylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro‐organisms and related public health effects.
Matti Lehtinen, Marc Lipsitch, Ville N. Pimenoff, Karin Sundström, Johannes Berkhof, Iacopo Baussano, Simopekka Vänskä, Joakim Dillner   +7 more
wiley   +1 more source

Prospects for controlling cervical cancer at the turn of the century

Salud Pública de México, 2003
Cervical cancer morbidity and mortality have decreased substantially during the last 50 years mostly due to success-ful organized or opportunistic screening with Pap cytology in high and middle income countries.
Franco Eduardo L, Duarte-Franco Eliane, Ferenczy Alex   +2 more
doaj  

The Cellular Bromodomain Protein Brd4 has Multiple Functions in E2-Mediated Papillomavirus Transcription Activation

Viruses, 2014
The cellular bromodomain protein Brd4 functions in multiple processes of the papillomavirus life cycle, including viral replication, genome maintenance, and gene transcription through its interaction with the viral protein, E2. However, the mechanisms by
Christine M. Helfer, Junpeng Yan, Jianxin You   +2 more
doaj   +1 more source

Papillomavirus E6 oncoproteins

Virology, 2013
Papillomaviruses induce benign and malignant epithelial tumors, and the viral E6 oncoprotein is essential for full transformation. E6 contributes to transformation by associating with cellular proteins, docking on specific acidic LXXLL peptide motifs found on these proteins.
Vande Pol, Scott B., Klingelhutz, Aloysius J.   +1 more
openaire   +2 more sources

Cancer detection using human papillomavirus self‐sampling targeting long‐term non‐attenders in an organized cervical screening program

International Journal of Cancer, EarlyView.
What's New? The strategy to offer self‐sampling for human papillomavirus testing to increase cervical cancer screening attendance among long‐term non‐attenders has been mostly validated in randomized trials. This real‐life implementation of self‐sampling for long‐term non‐attenders to the routine screening program in the capital region of Sweden ...
K. Miriam Elfström, Maria Hortlund, Daniel Öhman, Joakim Dillner   +3 more
wiley   +1 more source

Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile

Infectious Agents and Cancer, 2011
Background Human papillomavirus (HPV) and Epstein Barr virus (EBV) have been found in breast carcinomas (BCs) around the world. In this study, fifty-five BCs from Chile were analyzed for HPV and EBV presence.
Eizuru Yoshito, Solís Luisa, Padilla Oslando, Ampuero Sandra, González Carolina, Koriyama Chihaya, Khan Noureen, Aguayo Francisco, Corvalán Alejandro, Akiba Suminori   +9 more
doaj   +1 more source

Race‐specific temporal trends of HPV‐related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011–2022

International Journal of Cancer, EarlyView.
What's New? Racial disparities in trends of human papillomavirus (HPV)–associated cancers in South Africa have received limited attention. Here, the authors examined cancer incidence rates among South Africans, with stratification by race and sex, for different timeframes across 2011–2022.
Adino T. Tsegaye, Sizeka A. Mashele, Jaimie Z. Shing, Judith Mwansa‐Kambafwile, Aimée R. Kreimer, Carole Metekoua, Meredith S. Shiels, Mazvita Muchengeti   +7 more
wiley   +1 more source